Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2012 December;147(6) > Giornale Italiano di Dermatologia e Venereologia 2012 December;147(6):545-52

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014


eTOC

 

  CUTANEOUS LYMPHOMA: WHERE ARE WE MOVING?


Giornale Italiano di Dermatologia e Venereologia 2012 December;147(6):545-52

language: English

CD30+ lymphoproliferative disorders of the skin: still an open question

Alaibac M., Zarian H., Russo I., Peserico A.

Unit of Dermatology, University of Padua, Padua, Italy


PDF  


CD30+ lymphoproliferative disorders of the skin represent a well-defined spectrum of primary cutaneous T-cell lymphomas. They include lymphomatoid papulosis and cutaneous anaplastic large-cell lymphoma which are characterized by the common expression of the CD30 antigen, but different clinical, histological and molecular features. Recent progress in the pathobiology and identification of therapeutic targets has contributed to our current understanding of this peculiar group of cutaneous lymphoproliferative disorders. The characteristic features of this group of cutaneous lymphoproliferative disorders are reviewed with particular emphasis to their diagnosis and treatment strategies.

top of page

Publication History

Cite this article as

Corresponding author e-mail

mauro.alaibac@unipd.it